Home

divorț Vârf nervură cart hiv prăsilă conductor Băţ

HIV Integration at Certain Sites in Host DNA Is Linked to the Expansion and Persistence of Infected Cells | Poster
HIV Integration at Certain Sites in Host DNA Is Linked to the Expansion and Persistence of Infected Cells | Poster

Full article: Pharmacological suppression of glycogen synthase kinase-3 reactivates HIV-1 from latency via activating Wnt/β-catenin/TCF1 axis in CD4+ T cells
Full article: Pharmacological suppression of glycogen synthase kinase-3 reactivates HIV-1 from latency via activating Wnt/β-catenin/TCF1 axis in CD4+ T cells

Viruses | Free Full-Text | The Potential of Long-Acting, Tissue-Targeted Synthetic Nanotherapy for Delivery of Antiviral Therapy Against HIV Infection
Viruses | Free Full-Text | The Potential of Long-Acting, Tissue-Targeted Synthetic Nanotherapy for Delivery of Antiviral Therapy Against HIV Infection

Immunologic Interplay Between HIV/AIDS and COVID-19: Adding Fuel to the Flames? | Current HIV/AIDS Reports
Immunologic Interplay Between HIV/AIDS and COVID-19: Adding Fuel to the Flames? | Current HIV/AIDS Reports

A New Generation Of Novel HIV Small-Molecule Antivirals | Seeking Alpha
A New Generation Of Novel HIV Small-Molecule Antivirals | Seeking Alpha

Management of HIV/AIDS - Wikipedia
Management of HIV/AIDS - Wikipedia

Frontiers | Advances in Developing CAR T-Cell Therapy for HIV Cure
Frontiers | Advances in Developing CAR T-Cell Therapy for HIV Cure

Dopaminergic impact of cART and anti-depressants on HIV neuropathogenesis in older adults - ScienceDirect
Dopaminergic impact of cART and anti-depressants on HIV neuropathogenesis in older adults - ScienceDirect

HIV cure at CROI: new data on antibodies, vaccines and genetically engineered T-cells | aidsmap
HIV cure at CROI: new data on antibodies, vaccines and genetically engineered T-cells | aidsmap

SWORD Study: Switch to DTG + RPV
SWORD Study: Switch to DTG + RPV

Hypogonadism and bone health in men with HIV - The Lancet HIV
Hypogonadism and bone health in men with HIV - The Lancet HIV

Viruses | Free Full-Text | Eradication of HIV-1 from the Macrophage Reservoir: An Uncertain Goal?
Viruses | Free Full-Text | Eradication of HIV-1 from the Macrophage Reservoir: An Uncertain Goal?

Molecular Mechanisms Controlling HIV Transcription and Latency – Implications for Therapeutic Viral Reactivation | IntechOpen
Molecular Mechanisms Controlling HIV Transcription and Latency – Implications for Therapeutic Viral Reactivation | IntechOpen

HIV-1 transcription and latency: an update | Retrovirology | Full Text
HIV-1 transcription and latency: an update | Retrovirology | Full Text

Endothelial dysfunction in HIV + patients under combination... | Download Scientific Diagram
Endothelial dysfunction in HIV + patients under combination... | Download Scientific Diagram

Nanomedicine applications towards the cure of HIV - ScienceDirect
Nanomedicine applications towards the cure of HIV - ScienceDirect

Antiretroviral Drugs Alter the Content of Extracellular Vesicles from HIV-1-Infected Cells
Antiretroviral Drugs Alter the Content of Extracellular Vesicles from HIV-1-Infected Cells

Adding a second step to CAR T-cell therapy may make it effective against HIV | Frederick National Laboratory
Adding a second step to CAR T-cell therapy may make it effective against HIV | Frederick National Laboratory

Frontiers | Insulin Resistance in HIV-Patients: Causes and Consequences
Frontiers | Insulin Resistance in HIV-Patients: Causes and Consequences

Replacing cART with CAR-T Cells: Using Immunotherapy to Cure HIV: Molecular Therapy
Replacing cART with CAR-T Cells: Using Immunotherapy to Cure HIV: Molecular Therapy

Involvement of HIV-1 infection and cART in metabolic dysfunction in... | Download Scientific Diagram
Involvement of HIV-1 infection and cART in metabolic dysfunction in... | Download Scientific Diagram

The Role of Immunometabolism in HIV-1 Pathogenicity: Links to Immune Cell Responses
The Role of Immunometabolism in HIV-1 Pathogenicity: Links to Immune Cell Responses

JCI - TLR3 agonist and CD40-targeting vaccination induces immune responses and reduces HIV-1 reservoirs
JCI - TLR3 agonist and CD40-targeting vaccination induces immune responses and reduces HIV-1 reservoirs

Pipeline
Pipeline

Combined cART including Tenofovir Disoproxil, Emtricitabine, and Dolutegravir has potent therapeutic effects in HIV-1 infected humanized mice | Journal of Translational Medicine | Full Text
Combined cART including Tenofovir Disoproxil, Emtricitabine, and Dolutegravir has potent therapeutic effects in HIV-1 infected humanized mice | Journal of Translational Medicine | Full Text

Combination Antiretroviral Therapy (cART) for HIV
Combination Antiretroviral Therapy (cART) for HIV

HIV-1 viremia and viral recrudesce in cART or cART plus IFNα14 treated... | Download Scientific Diagram
HIV-1 viremia and viral recrudesce in cART or cART plus IFNα14 treated... | Download Scientific Diagram

JCI - Blocking type I interferon signaling enhances T cell recovery and reduces HIV-1 reservoirs
JCI - Blocking type I interferon signaling enhances T cell recovery and reduces HIV-1 reservoirs

HIV, Combination Antiretroviral Therapy, and Vascular Diseases in Men and Women - ScienceDirect
HIV, Combination Antiretroviral Therapy, and Vascular Diseases in Men and Women - ScienceDirect